Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8428764 | Trends in Food Science & Technology | 2017 | 44 Pages |
Abstract
Sulforaphane, as a pure chemical, protects against chemical-induced skin, oral, stomach, colon, lung and bladder carcinogenesis and in genetic models of colon and prostate carcinogenesis. In many of these settings the antitumorigenic efficacy of sulforaphane is dampened in Nrf2-disrupted animals. Broccoli preparations rich in glucoraphanin or sulforaphane exert demonstrable pharmacodynamic action in over a score of clinical trials. Measures of NRF2 pathway response and function are serving as guideposts for the optimization of dose, schedule and formulation as clinical trials with broccoli-based preparations become more commonplace and more rigorous in design and implementation.
Related Topics
Life Sciences
Agricultural and Biological Sciences
Food Science
Authors
Albena T. Dinkova-Kostova, Jed W. Fahey, Rumen V. Kostov, Thomas W. Kensler,